(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide

C138H153BrFN29O14S4 — CID 157211713

IUPAC(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide
SMILESCCCNC(=O)c1cccc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)c1.CN1C(=O)C(C)(c2ccnc(Br)c2)N=C1N.CN1C(=O)C[C@@](C)(C2CCCN(S(=O)(=O)c3cccc(F)c3)C2)N=C1N.CN1C(=O)C[C@@](C)(c2ccc3cnn(CC4CC4)c3c2)N=C1N.CS(=O)(=O)N1CCCC(CCN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)C1.C[C@@]1(c2ccc3sccc3c2)CC(=O)N(CCc2ccccn2)C(N)=N1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1ccc(NS(=O)(=O)C2CC2)cc1
InChIInChI=1S/C26H26N4O2.C25H24N4O3S.C23H28N4O3S.C20H20N4OS.C17H23FN4O3S.C17H21N5O.C10H11BrN4O/c1-2-16-28-23(31)20-11-9-10-19(17-20)18-30-24(32)26(29-25(30)27,21-12-5-3-6-13-21)22-14-7-4-8-15-22;26-24-27-25(19-7-3-1-4-8-19,20-9-5-2-6-10-20)23(30)29(24)17-18-11-13-21(14-12-18)28-33(31,32)22-15-16-22;1-31(29,30)26-15-8-9-18(17-26)14-16-27-21(28)23(25-22(27)24,19-10-4-2-5-11-19)20-12-6-3-7-13-20;1-20(15-5-6-17-14(12-15)8-11-26-17)13-18(25)24(19(21)23-20)10-7-16-4-2-3-9-22-16;1-17(10-15(23)21(2)16(19)20-17)12-5-4-8-22(11-12)26(24,25)14-7-3-6-13(18)9-14;1-17(8-15(23)21(2)16(18)20-17)13-6-5-12-9-19-22(14(12)7-13)10-11-3-4-11;1-10(6-3-4-13-7(11)5-6)8(16)15(2)9(12)14-10/h3-15,17H,2,16,18H2,1H3,(H2,27,29)(H,28,31);1-14,22,28H,15-17H2,(H2,26,27);2-7,10-13,18H,8-9,14-17H2,1H3,(H2,24,25);2-6,8-9,11-12H,7,10,13H2,1H3,(H2,21,23);3,6-7,9,12H,4-5,8,10-11H2,1-2H3,(H2,19,20);5-7,9,11H,3-4,8,10H2,1-2H3,(H2,18,20);3-5H,1-2H3,(H2,12,14)/t;;;20-;12?,17-;17-;/m...000./s1
InChIKeyARYQSDBAVODRES-OTBFVKEDSA-N
MW2669.10 g/mol
LogP15.91
Rot. Bonds31

About (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide

(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide (PubChem CID 157211713) has the molecular formula C138H153BrFN29O14S4 and a molecular weight of 2669.10 g/mol. Its IUPAC name is (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide.

Molecular Properties

Compound Name(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide
PubChem CID157211713
Molecular FormulaC138H153BrFN29O14S4
Molecular Weight2669.10 g/mol
Exact Mass2666.02
IUPAC Name(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide
SMILESCCCNC(=O)c1cccc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)c1.CN1C(=O)C(C)(c2ccnc(Br)c2)N=C1N.CN1C(=O)C[C@@](C)(C2CCCN(S(=O)(=O)c3cccc(F)c3)C2)N=C1N.CN1C(=O)C[C@@](C)(c2ccc3cnn(CC4CC4)c3c2)N=C1N.CS(=O)(=O)N1CCCC(CCN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)C1.C[C@@]1(c2ccc3sccc3c2)CC(=O)N(CCc2ccccn2)C(N)=N1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1ccc(NS(=O)(=O)C2CC2)cc1
InChIInChI=1S/C26H26N4O2.C25H24N4O3S.C23H28N4O3S.C20H20N4OS.C17H23FN4O3S.C17H21N5O.C10H11BrN4O/c1-2-16-28-23(31)20-11-9-10-19(17-20)18-30-24(32)26(29-25(30)27,21-12-5-3-6-13-21)22-14-7-4-8-15-22;26-24-27-25(19-7-3-1-4-8-19,20-9-5-2-6-10-20)23(30)29(24)17-18-11-13-21(14-12-18)28-33(31,32)22-15-16-22;1-31(29,30)26-15-8-9-18(17-26)14-16-27-21(28)23(25-22(27)24,19-10-4-2-5-11-19)20-12-6-3-7-13-20;1-20(15-5-6-17-14(12-15)8-11-26-17)13-18(25)24(19(21)23-20)10-7-16-4-2-3-9-22-16;1-17(10-15(23)21(2)16(19)20-17)12-5-4-8-22(11-12)26(24,25)14-7-3-6-13(18)9-14;1-17(8-15(23)21(2)16(18)20-17)13-6-5-12-9-19-22(14(12)7-13)10-11-3-4-11;1-10(6-3-4-13-7(11)5-6)8(16)15(2)9(12)14-10/h3-15,17H,2,16,18H2,1H3,(H2,27,29)(H,28,31);1-14,22,28H,15-17H2,(H2,26,27);2-7,10-13,18H,8-9,14-17H2,1H3,(H2,24,25);2-6,8-9,11-12H,7,10,13H2,1H3,(H2,21,23);3,6-7,9,12H,4-5,8,10-11H2,1-2H3,(H2,19,20);5-7,9,11H,3-4,8,10H2,1-2H3,(H2,18,20);3-5H,1-2H3,(H2,12,14)/t;;;20-;12?,17-;17-;/m...000./s1
InChIKeyARYQSDBAVODRES-OTBFVKEDSA-N
XLogP15.91
TPSA604.46 Ų
H-Bond Donors9
H-Bond Acceptors33
Rotatable Bonds31
Heavy Atoms187
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002669.10
LogP ≤ 515.91
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[[(4S)-2-amino-4-(1-benzothiophen-5-yl)-4-methyl-6-oxo-5H-pyrimidin-1-yl]methyl]-N-butylbenzamide;(5S,6S)-2-amino-5-(4-cyclopropylphenyl)-3,6-dimethyl-6-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-5H-pyrimidin-4-one;(5R,6S)-2-amino-5-(4-cyclopropylphenyl)-3,6-dimethyl-6-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-5H-pyrimidin-4-one;(5S,6R)-2-amino-6-(3,4-dibromothiophen-2-yl)-5-iodo-3,6-dimethyl-5H-pyrimidin-4-one;(5R,6R)-2-amino-6-(3,4-dibromothiophen-2-yl)-5-iodo-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-[1-(thiophen-3-ylmethyl)piperidin-3-yl]-5H-pyrimidin-4-one;2-amino-5-(2-fluoro-5-pyridin-4-ylphenyl)-3,5-dimethylimidazol-4-one
CID 158503125
(5S)-2-amino-5-(cyclohexylmethyl)-5-cyclopropyl-3-methylimidazol-4-one;3-[5-[(4S,5S)-2-amino-1,4-dimethyl-6-oxo-5-(4-propan-2-ylsulfonylphenyl)-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;3-[5-[(4S,5R)-2-amino-1,4-dimethyl-6-oxo-5-(4-propan-2-ylsulfonylphenyl)-5H-pyrimidin-4-yl]thiophen-3-yl]benzonitrile;(6S)-2-amino-3,6-dimethyl-6-(3-pentyl-2H-indazol-5-yl)-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(4-pyridin-3-yl-2-pyridinyl)-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-[1-(thiophene-2-carbonyl)piperidin-3-yl]-5H-pyrimidin-4-one
CID 160835446
3-[[(4S)-2-amino-4-(1-benzothiophen-5-yl)-4-methyl-6-oxo-5H-pyrimidin-1-yl]methyl]-N-benzylbenzamide;3-[5-[(4S,5R)-2-amino-5-(4-tert-butylphenyl)-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]thiophen-2-yl]benzonitrile;(5S,6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;(5R,6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-5-(4-cyclopropylphenyl)-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-methyl-5-phenyl-5-[3-(pyridin-2-ylmethylamino)phenyl]imidazol-4-one
CID 161332280

Frequently Asked Questions

What is the IUPAC name of (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide?
The IUPAC name of (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide (CID 157211713) is (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide.
What is the SMILES notation for (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide?
The canonical SMILES for (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide is CCCNC(=O)c1cccc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)c1.CN1C(=O)C(C)(c2ccnc(Br)c2)N=C1N.CN1C(=O)C[C@@](C)(C2CCCN(S(=O)(=O)c3cccc(F)c3)C2)N=C1N.CN1C(=O)C[C@@](C)(c2ccc3cnn(CC4CC4)c3c2)N=C1N.CS(=O)(=O)N1CCCC(CCN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)C1.C[C@@]1(c2ccc3sccc3c2)CC(=O)N(CCc2ccccn2)C(N)=N1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1Cc1ccc(NS(=O)(=O)C2CC2)cc1.
What is the InChIKey of (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide?
The InChIKey is ARYQSDBAVODRES-OTBFVKEDSA-N. The full InChI is InChI=1S/C26H26N4O2.C25H24N4O3S.C23H28N4O3S.C20H20N4OS.C17H23FN4O3S.C17H21N5O.C10H11BrN4O/c1-2-16-28-23(31)20-11-9-10-19(17-20)18-30-24(32)26(29-25(30)27,21-12-5-3-6-13-21)22-14-7-4-8-15-22;26-24-27-25(19-7-3-1-4-8-19,20-9-5-2-6-10-20)23(30)29(24)17-18-11-13-21(14-12-18)28-33(31,32)22-15-16-22;1-31(29,30)26-15-8-9-18(17-26)14-16-27-21(28)23(25-22(27)24,19-10-4-2-5-11-19)20-12-6-3-7-13-20;1-20(15-5-6-17-14(12-15)8-11-26-17)13-18(25)24(19(21)23-20)10-7-16-4-2-3-9-22-16;1-17(10-15(23)21(2)16(19)20-17)12-5-4-8-22(11-12)26(24,25)14-7-3-6-13(18)9-14;1-17(8-15(23)21(2)16(18)20-17)13-6-5-12-9-19-22(14(12)7-13)10-11-3-4-11;1-10(6-3-4-13-7(11)5-6)8(16)15(2)9(12)14-10/h3-15,17H,2,16,18H2,1H3,(H2,27,29)(H,28,31);1-14,22,28H,15-17H2,(H2,26,27);2-7,10-13,18H,8-9,14-17H2,1H3,(H2,24,25);2-6,8-9,11-12H,7,10,13H2,1H3,(H2,21,23);3,6-7,9,12H,4-5,8,10-11H2,1-2H3,(H2,19,20);5-7,9,11H,3-4,8,10H2,1-2H3,(H2,18,20);3-5H,1-2H3,(H2,12,14)/t;;;20-;12?,17-;17-;/m...000./s1.
What are the key properties of (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide?
(6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide has a molecular weight of 2669.10 g/mol, XLogP of 15.91, 31 rotatable bonds, 9 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for (6S)-2-amino-6-(1-benzothiophen-5-yl)-6-methyl-3-(2-pyridin-2-ylethyl)-5H-pyrimidin-4-one;2-amino-5-(2-bromo-4-pyridinyl)-3,5-dimethylimidazol-4-one;(6S)-2-amino-6-[1-(cyclopropylmethyl)indazol-6-yl]-3,6-dimethyl-5H-pyrimidin-4-one;(6S)-2-amino-6-[1-(3-fluorophenyl)sulfonylpiperidin-3-yl]-3,6-dimethyl-5H-pyrimidin-4-one;2-amino-3-[2-(1-methylsulfonylpiperidin-3-yl)ethyl]-5,5-diphenylimidazol-4-one;N-[4-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]phenyl]cyclopropanesulfonamide;3-[(2-amino-5-oxo-4,4-diphenylimidazol-1-yl)methyl]-N-propylbenzamide is sourced from PubChem (CID 157211713), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).